1028310-65-7

Basic information

• Product Name: (E)-1-[2,5-Bis-(tetrahydro-pyran-2-yloxy)-phenyl]-3-(2-bromo-5-hydroxy-phenyl)-propenone
• Synonyms: (E)-1-[2,5-Bis-(tetrahydro-pyran-2-yloxy)-phenyl]-3-(2-bromo-5-hydroxy-phenyl)-propenone
• CAS NO: 1028310-65-7
• Molecular Weight: 503.39
• Mol File: 1028310-65-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (E)-1-[2,5-Bis-(tetrahydro-pyran-2-yloxy)-phenyl]-3-(2-bromo-5-hydroxy-phenyl)-propenone(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-1-[2,5-Bis-(tetrahydro-pyran-2-yloxy)-phenyl]-3-(2-bromo-5-hydroxy-phenyl)-propenone(1028310-65-7)
• EPA Substance Registry System: (E)-1-[2,5-Bis-(tetrahydro-pyran-2-yloxy)-phenyl]-3-(2-bromo-5-hydroxy-phenyl)-propenone(1028310-65-7)

Safety Data

• Hazardous Substances Data: 1028310-65-7(Hazardous Substances Data)

Upstream product

• 2973-80-0 2-bromo-5-hydroxybenzaldehyde 
• 204703-68-4 2',5'-bis(3,4,5,6-tetrahydro-2H-pyran-2-yloxy)acetophenone 

Relevant articles and documents

Cytotoxic 2',5'-dihydroxychalcones with unexpected antiangiogenic activity.

A series of 2',5'-dihydroxychalcones were synthesized and evaluated for cytotoxicity against tumor cell lines and human umbilical venous endothelial cells (HUVEC). It was found that chalcones with electron-withdrawing substituents on the B ring exhibited potent cytotoxicity against a variety of tumor cell lines while compounds with electron-releasing groups were less potent in general. Those compounds with B ring replaced by extended or heteroaromatic rings exhibited significant bioactivity. Several compounds were shown to have marked cytotoxic selectivity towards HUVECs. Especially, among the synthesized compounds, 2-chloro-2',5'-dihydroxychalcone (2-3) showed the highest selectivity index up to 66 in comparison to HCT116 cells. This compound also exhibited strong inhibitory effects on the HUVEC tube formation in an in vitro model. When administered into BDF1 mice bearing Lewis lung carcinoma cells at 50 mg kg(-1) day(-1), 2-3 was found to inhibit the growth of tumor mass by 60.5%.